Cameron Pitt
Fundador en Quanta Therapeutics, Inc. .
Perfil
Cameron Pitt is the founder of Quanta Therapeutics, Inc. founded in 2018, where he holds the title of Director & Chief Business Officer.
In 2018, he also started working at Sofinnova Investments, Inc. as a Principal until 2020.
Dr. Pitt has an undergraduate degree from Stanford University and a doctorate from the University of California.
Cargos activos de Cameron Pitt
Empresas | Cargo | Inicio |
---|---|---|
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Fundador | 01/01/2018 |
Antiguos cargos conocidos de Cameron Pitt.
Empresas | Cargo | Fin |
---|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Analista de Capital Privado | 30/04/2020 |
Formación de Cameron Pitt.
University of California | Doctorate Degree |
Stanford University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Cameron Pitt